Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Amylyx Pharmaceuticals' Q3 Net Loss Widens

Amylyx Pharmaceuticals' Q3 Net Loss Widens

MT newswireMT newswire2026/11/05 13:24
09:24 AM EST, 11/05/2026 (MT Newswires) -- Amylyx Pharmaceuticals (AMLX) reported a Q3 net loss Thursday of $0.38 per diluted share, widening from a loss of $0.37 a year earlier. Analysts surveyed by FactSet expected a loss of $0.38. No revenue for the quarter ended Sept. 30 was reported. As of Sept. 30, the company said it had $768.1 million in cash, cash equivalents and marketable securities. Shares of Amylyx Pharmaceuticals were up 1.6% pre-bell.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Elon Musk speaks out again: It would be my honor to hire Jensen Huang

On November 12 local time, the well-known financial commentary account ZeroHedge posted on social platform X, calling out to Musk: "Elon please hire Jensen." Musk immediately responded: "That would be an honor."

华尔街见闻•2026/11/12 06:36